Home/Cervical Cancer
Condition Deep-Dive

Cervical Cancer

A cancer that is nearly always caused by persistent high-risk HPV infection1 and, uniquely among major cancers, is preventable through vaccination and detectable at the precancer stage through routine screening. Holistic nutrition is a complement to oncology, not a substitute for it.

Hormonal & Women's Health Evidence-Based

Last updated:

โš ๏ธ Treatment safety: please read first. The nutrition and supplement approaches on this page are meant to work alongside cancer treatment, never to replace or delay it. Never stop, delay or change your treatment without your oncology team's guidance. Doing so can be dangerous. Several supplements interact with chemotherapy and other cancer treatments, so talk to your oncology team or pharmacist before starting anything on this page.
Definition

What Is Cervical Cancer?

Cervical cancer is a malignancy of the cervix, the lower, narrow portion of the uterus that opens into the vagina. In virtually all cases, it begins with persistent infection by a high-risk strain of the human papillomavirus (HPV), most commonly HPV 16 or 18.

The disease develops slowly. Most HPV infections clear on their own within 1 to 2 years through normal immune surveillance. When infection persists rather than clearing, the virus can integrate into cervical epithelial cells and gradually drive precancerous changes, called cervical intraepithelial neoplasia (CIN 1, 2 or 3), before progressing to invasive cancer. This long window is precisely why Pap smears and HPV co-testing are so effective at preventing the disease.

The two dominant histologic subtypes account for most cases and arise from different cell populations within the cervix. FIGO staging (I to IV) describes how far the cancer has spread beyond the cervix and guides treatment4.

Cervical cancer, the uterus, cervix and vagina with a tumor on the cervix and a magnified view of it

Squamous Cell Carcinoma

Arises from the squamous epithelial cells of the ectocervix (the outer surface that faces the vagina). The most common subtype and the one most reliably detected by traditional Pap cytology. Typically slow-growing through CIN precursor lesions.

  • โ†’Origin: Squamocolumnar junction (transformation zone) of the ectocervix
  • โ†’HPV strains: Predominantly HPV 16; also 18, 31, 33, 45, 52, 58
  • โ†’Behavior: Generally responsive to surgery, radiation and chemoradiation4

Adenocarcinoma

Arises from the glandular cells of the endocervical canal (inner cervix). Harder to catch on Pap because it sits higher in the canal, which is one reason HPV co-testing has become standard.

  • โ†’Origin: Glandular endocervical cells, higher in the canal
  • โ†’HPV strains: HPV 16 and HPV 18

Adenosquamous & Other Mixed

Mixed glandular and squamous tumors. Generally treated similarly to the dominant component but tend to behave more aggressively than pure squamous tumors. Carefully reviewed by gynecologic-oncology pathology.

  • โ†’Origin: Both ecto- and endocervical components
  • โ†’HPV: Still HPV-driven in most cases

Rare Subtypes (Small-Cell Neuroendocrine, Clear-Cell, Sarcoma)

Small-cell neuroendocrine carcinoma is aggressive and treated more like small-cell lung cancer. Clear-cell carcinoma has historically been linked to exposure in the womb to DES (diethylstilbestrol), a drug once given in pregnancy. These are rare19 but require specialized protocols.

  • โ†’Small-cell neuroendocrine: Aggressive, platinum + etoposide chemo regimens
  • โ†’Cervical sarcoma: Very rare mesenchymal origin
  • โ†’Care: Tertiary gynecologic-oncology center is strongly preferred
โš ๏ธ Important: Cervical cancer requires gynecologic-oncology care. The information on this page is educational and describes complementary nutrition and lifestyle support that may be used alongside (not instead of) surgery, chemotherapy, radiation or immunotherapy. Always coordinate any supplement with your oncology team, as some can interact with chemotherapy or radiation.
By the Numbers

Cervical Cancer by the Numbers

~13,500
new invasive cervical cancers projected in the US for 2026 15
99.7%
of cervical cancer specimens worldwide contained HPV DNA in a 1999 analysis21
~4,200
US deaths from cervical cancer projected for 2026 15
~92%
five-year relative survival while the cancer is confined to the cervix, against about 21% once it has spread to distant organs (US, 2016 to 2022)15
88%
lower rate of CIN 2 or worse at age 20 in Scottish women vaccinated against HPV at 12 to 13; protection against CIN 3 or worse was 86% when given at 12 to 13 and 51% at 17 8
15 to 20 years
usual time for abnormal cervical cells to become cancer, and 5 to 10 years with a weakened immune system such as untreated HIV20
Signs & Symptoms

Symptoms of Cervical Cancer

Early-stage cervical cancer and its precancer precursors are usually silent, which is why screening matters far more than symptom-watching. Once symptoms appear, the disease is typically already invasive. Any abnormal bleeding warrants prompt evaluation.

SymptomWhat happens
Early Local Symptoms
Postcoital BleedingLight spotting or frank bleeding after intercourse is one of the most classic early warnings of an invasive cervical lesion. Any episode warrants a prompt pelvic exam and Pap/HPV testing rather than waiting it out.
Intermenstrual (Between-Period) BleedingUnexpected spotting or bleeding between regular periods. While many benign causes exist (polyps, hormonal shifts), persistent intermenstrual bleeding must be evaluated to rule out cervical or endometrial pathology.
Watery, Bloody or Foul-Smelling Vaginal DischargeA persistent thin, watery discharge, sometimes blood-tinged or with an offensive odor.
Heavier or Longer PeriodsA clear change in menstrual pattern, periods becoming much heavier, longer or accompanied by clots, deserves attention.
Postmenopausal BleedingAny bleeding after menopause is abnormal and must be investigated. While endometrial cancer is the more common cause, cervical cancer is on the differential.
Pain During Intercourse or Pelvic AcheDeep pain during intercourse (dyspareunia) or a persistent low-grade pelvic ache.
Locally Advanced & Systemic Signs
Persistent Pelvic or Lower Back PainA dull, deep ache in the pelvis or low back, sometimes radiating into the legs, can reflect tumor extension into the parametrium, pelvic side wall or nerves. This is a later-stage finding and warrants urgent imaging.
Unilateral Leg Swelling (Lymphedema)Swelling of one leg can develop when enlarged pelvic lymph nodes obstruct lymph drainage. This is a worrying sign of locally advanced disease and warrants urgent CT or MRI of the pelvis.
Urinary Symptoms (Frequency, Hematuria, Obstruction)Tumor extension toward the bladder or ureters can cause urinary frequency, blood in the urine or blocked drainage from the kidneys. Any blood in the urine or sudden flank pain demands evaluation.
Bowel Symptoms (Constipation, Rectal Bleeding)Posterior tumor extension can compress or invade the rectum, leading to constipation, narrow stools or rectal bleeding.
Unintended Weight Loss & Profound FatigueSystemic symptoms of advanced cancer, including unexplained weight loss, loss of appetite and fatigue that does not improve with rest.
Cough, Bone Pain or Other Distant SymptomsA new persistent cough, bone pain (especially in the spine or pelvis) or jaundice in someone with known cervical cancer requires urgent staging imaging.
โš ๏ธ Pattern to watch for: Postcoital bleeding, intermenstrual bleeding or any postmenopausal bleeding, particularly in someone who has skipped routine Pap/HPV screening3, must be evaluated promptly. Cervical cancer is most curable when caught at the precancer stage or Stage I.
Causes

Causes of Cervical Cancer

Nearly all cervical cancers are caused by infection with high-risk types of HPV22. Most infections clear on their own; the factors below make it more likely that an infection persists or that abnormal cells progress20.

CauseHow It Contributes to Cervical CancerWhat Helps
Persistent high-risk HPV infectionThe immune system usually clears HPV, but persistent infection with high-risk types can lead to precancer and, untreated, to cancer; types 16 and 18 cause around 76% of cervical cancers20HPV vaccination, offered in the US routinely at 11 or 12 with catch-up through age 26 23 and in the UK at 12 to 13 with catch-up to the 25th birthday24; screening, and treatment of any precancer it finds3
Weakened immunity, including HIVWomen living with HIV are 6 times more likely to develop cervical cancer, and abnormal cells can progress in 5 to 10 years rather than 15 to 20 20Effective HIV treatment and closer screening: WHO advises screening every 3 to 5 years from age 25 for women living with HIV20
SmokingSmoking weakens the immune system, and chemicals in cigarettes can also cause cervical cancer22Stopping smoking
Long-term birth control pill use and several birthsTaking the pill for more than 5 years slightly raises risk, and so does having several children or a first child before 17 22A conversation with your doctor about contraception; for many people the pill's benefits outweigh this small risk22
Other genital infectionsOther sexually transmitted infections are among the factors that raise the risk of progression20, and bacterial vaginosis is associated with cervical HPV infection12Testing and treatment of infections; condoms lower the chance of catching HPV, though they do not cover all the skin around the genitals22
Missed screeningMost cervical cancers occur in people who were never screened or not screened on schedule3Getting screened on schedule; if you missed your last test, book one now rather than waiting14
Diagnosis

How Cervical Cancer Is Diagnosed

Diagnosis moves from routine screening (Pap and HPV testing) to confirmatory colposcopy4 with biopsy, then to staging imaging. Alongside vaccination, the highest-leverage step is staying current on screening, because most cervical cancers occur in people who were never screened or not screened on schedule3.

TestWhat it shows
At-Home & Patient-Driven Steps
Track Your Screening ScheduleKnow exactly when your last Pap and HPV test were done and when the next is due. In the US: a Pap test every 3 years from 21 to 29; from 30 to 65, a Pap test every 3 years, an HPV test every 5 years or both together every 5 years13. In the UK, the NHS invites everyone with a cervix every 5 years from 25 to 64 14.
Self-Collected HPV Sampling (Where Available)FDA-cleared self-collection HPV kits are increasingly available in clinics and home programs. These can be excellent for patients who have avoided pelvic exams due to trauma, dysphoria or access barriers. Discuss with your provider; abnormal results still require an in-clinic follow-up.
Clinical Diagnostic Workup
Pap (Cervical Cytology) and Primary HPV TestingIn the 30 to 65 age range, primary HPV testing or co-testing is more sensitive than Pap alone, particularly for adenocarcinoma precursors hidden in the endocervical canal.
Colposcopy with Directed BiopsyIndicated for any abnormal Pap or HPV-positive result depending on risk thresholds. The cervix is magnified, painted with acetic acid and Lugol's iodine, and any abnormal areas are biopsied.
Excisional Procedures (LEEP, Cone Biopsy)Loop electrosurgical excision procedure (LEEP) or cold-knife cone biopsy is used both to treat high-grade CIN (CIN 2/3, AIS) and to definitively rule out occult invasive disease.
Staging Imaging (MRI, PET-CT)Once invasive cancer is confirmed, pelvic MRI is the gold standard for assessing local tumor size, parametrial invasion and lymph nodes. PET-CT is used for nodal and distant metastasis evaluation in higher-stage disease.
Examination Under Anesthesia & Cystoscopy/​ProctoscopyFor bulkier or locally advanced lesions, gynecologic oncology may perform an EUA to fully assess parametrial extension, plus cystoscopy and/or proctoscopy if bladder or bowel involvement is suspected.
Baseline Labs for Treatment PlanningComplete blood count, comprehensive metabolic panel, renal function, liver function, and (if chemotherapy is planned) cardiac and pulmonary baselines. An HIV test matters too: women living with HIV are 6 times more likely to develop cervical cancer20.
Treatment Comparison

Conventional and Holistic Treatment for Cervical Cancer

For invasive cervical cancer, conventional oncology is the standard of care and is curative for most patients caught early. Holistic strategies are a complement to that care, mainly by supporting nutrition and managing side effects during treatment5; evidence that diet or supplements clear HPV or prevent recurrence is limited to associations and small trials6. They are not a substitute.

๐ŸŒฟ HOLISTIC
๐Ÿ’Š CONVENTIONAL
๐ŸŒฟ

Holistic / Functional Approach

Good nutrition at the precancer stage, microbiome and mucosal health, and supportive care during oncology treatment

Primary Focus
Anti-inflammatory, immune-supportive nutrition + targeted micronutrients (folate, B12 and vitamin D where levels are low) + cervicovaginal microbiome support
Duration
Ongoing, alongside screening follow-up at the precancer stage and alongside oncology treatment if cancer is invasive
Effect on Underlying Disorder
Better nutrient status is associated with HPV clearance in observational studies, not proven to cause it6; supportive only for invasive disease
Role in Recovery
Reduce side effects, maintain weight and muscle, support post-treatment immune reconstitution

Full Holistic Approach Includes

  • HPV vaccination, routinely in adolescence with catch-up for young adults, and by shared decision with a clinician up to age 45 2; vaccination is the highest-leverage prevention step2
  • Strict on-schedule Pap/HPV screening; never skip a cycle, even in remission
  • Anti-inflammatory whole-food eating, abundant cruciferous vegetables, berries, leafy greens, fatty fish, extra-virgin olive oil
  • Folate- and B12-⁠rich foods: leafy greens, eggs, liver, lentils; better folate status is associated with HPV clearance in observational studies, not proven to cause it6
  • Correcting deficiencies your clinician finds, such as vitamin D, folate and B12, rather than supplementing to clear HPV6
  • Green tea extract and DIM, studied at the CIN stage, are not recommended: their trials found no benefit over placebo910. A shiitake mycelium extract cleared HPV more often than placebo in one small trial11. None of them replaces follow-up.
  • Cervicovaginal microbiome support, Lactobacillus-dominant flora through diet, fermented foods and oral probiotics with cervicovaginal strains
  • Smoking cessation (smoking is an established cofactor for cervical cancer)1
  • Mind-body work, stress management, sleep, gentle movement, and trauma-informed pelvic care during and after treatment
  • Always coordinated with the oncology team; some supplements interact with chemo or radiation and must be paused on schedule
โš ๏ธ Side effects: Generally well-tolerated when food-first and personalized. Watch antioxidant timing around chemo/​radiation: high-dose antioxidants are typically paused during active treatment days per the oncology team to avoid blunting therapeutic oxidative stress.
Supplement Protocol

Evidence-Based Supplements for Cervical Cancer

Evidence that supplements clear HPV at the precancer stage is limited to small and mixed trials6; their main roles are correcting deficiencies and supportive care during and after oncology treatment. Every supplement below must be cleared with the oncology team, because several can interact with chemo or radiation.

Supplement What it is for Typical range Timing Notes & cautions
Cultured shiitake mycelium extractMushroom-derived immune modulator. In one small randomized phase II trial in women with persistent high-risk HPV, 14 of 22 taking the extract tested HPV negative after 6 months, and 2 of 19 on placebo tested negative at 12 months; the trial reported the two groups at different time points, so the figures are not a like-for-like comparison11. Promising, but not yet confirmed in larger trials.3 g per dayEmpty stomach, morningBest studied at the persistent-HPV / precancer stage. Coordinate with oncology if on active treatment. Safety in pregnancy is not established; check with your midwife or doctor.
FolateFolate supports DNA synthesis and repair. Low folate status is associated with HPV persistence in observational studies; supplementation has not been shown to slow CIN progression6.400 to 800 mcg per dayMorning with foodFolic acid or methylfolate both work. Confirm B12 status before high-dose folate; pair with B12.
Vitamin B12Cofactor with folate in methylation; deficiency impairs cervical cell repair. Common in vegetarians, after PPIs or with malabsorption.500 to 1,000 mcg per dayMorning, sublingual or oralSublingual preferred when absorption is reduced. Retest serum B12 and MMA after 3 months.
Vitamin D3 (with K2)Involved in innate immunity and cell-cycle control. Correcting a deficiency is reasonable; supplementation has not been shown to clear HPV6.D3: set the dose with your clinician; most adults need no blood test first; K2 (MK-⁠7): 100 to 200 mcg per dayWith a fat-containing meal, morning preferredIf you take warfarin, clear any vitamin K supplement with the clinician managing your anticoagulation before starting or stopping it: vitamin K antagonizes warfarin, and changing your intake destabilizes the INR. Consistency matters more than avoidance. This does not apply in the same way to direct oral anticoagulants such as apixaban or rivaroxaban, but tell your prescriber about any supplement you take.
EGCG (Green Tea Extract)An early small study reported regression of cervical lesions with green tea extract, but a randomized placebo-controlled trial of 800 mg EGCG daily for 4 months in low-grade CIN found no improvement in HPV or lesion clearance9. Inhibits HPV E6/E7 oncoproteins in cell models.Not recommended for cervical lesions (the trial used 800 mg a day)Not applicablePause during chemotherapy days; may interact with bortezomib. Hepatotoxicity rare but possible; avoid if liver disease. The extract contains caffeine: if you are or might be pregnant, ask your midwife or doctor first17.
DIM (Diindolylmethane)A cruciferous-vegetable compound. In a randomized trial in CIN 2 or 3, lesions improved as often on placebo as on DIM, with no significant difference between the groups10.Not recommendedNot applicableThe trial found no benefit over placebo; eat cruciferous vegetables instead.
ZincRequired for antiviral T-cell function and cervical epithelial repair. Mild deficiency is common in vegetarians and during stress.15 to 30 mg per dayWith mealsFor long-term use over 8 weeks at higher doses, add 1 to 2 mg copper to prevent imbalance.
Vitamin CSupports antiviral immunity and collagen integrity of cervical stroma. Observational data link low vitamin C status to higher CIN risk.500 to 1,000 mg per daySplit, AM and middayHigh-dose IV vitamin C is sometimes used in integrative oncology; only under qualified integrative-oncology supervision and away from chemo days.
Omega-⁠3 EPA/DHAReduces systemic inflammation and may improve treatment tolerability and lean-mass preservation during chemoradiation.2 to 3 g combined EPA+DHA per dayWith mealsChoose a third-party tested product for purity. Discuss bleeding risk with oncology before surgery. In heart trials, fish oil supplements raised the risk of atrial fibrillation, an irregular heartbeat, more so above 1 g a day30, so check this dose with your clinician first.
Multi-Strain Probiotic (incl. cervicovaginal Lactobacillus)In a pooled analysis of 23 randomized trials in pelvic radiation therapy, probiotics lowered the risk of diarrhea18. Specific Lactobacillus crispatus / rhamnosus strains can be used vaginally.25 to 50 billion CFU per dayEmpty stomach or with light mealDiscuss with oncology if neutropenic. Vaginal probiotic use must be paused around active radiation.
Glutamine (L-Glutamine)Studied for radiation-related diarrhea, but in a pooled analysis of randomized trials in pelvic radiation therapy it had no effect on acute bowel symptoms18.Not recommended for radiation diarrhea (pooled trials found no effect)Not applicableDiscuss with oncology before use, particularly with an active malignancy. Safety of high doses in pregnancy is not established; check with your midwife or doctor.
Magnesium GlycinateSupports sleep, GI motility and stress recovery during treatment; often depleted by chemotherapy and proton pump inhibitors.200 to 400 mg elemental magnesium per dayEvening, 30 to 60 min before bedReduce dose if loose stools. The top of this range is above the 350 mg/day upper intake level for supplemental magnesium; above that, diarrhea is common. With kidney disease, take it only on your clinician's advice.
What to Expect

What to Expect Over Time

What happens depends on whether screening found precancer or cancer, and on the stage4.

Treatment and supportive care, together
First Weeks

An abnormal screening result leads to colposcopy and biopsy. Abnormal cell changes often return to normal in younger women14; high-grade changes are removed with a small excision4. If cancer is found, imaging sets the stage and the plan; ask about fertility-sparing options before treatment starts4.

Months 1 to 3

Early cancer is usually treated with surgery, and locally advanced cancer with chemoradiation4. Pelvic radiation therapy commonly causes diarrhea, so keeping up protein and energy and correcting anemia matter5. Exercise during treatment improves fitness and fatigue25.

Months 3 to 12

Follow-up visits and tests on the schedule your team sets. Supplements are for correcting documented deficiencies; none has been shown in large trials to clear HPV, and none has been shown to prevent cervical cancer6.

Long Term

Keep up follow-up and screening after treatment. Vaccination does not replace screening, because vaccines do not cover every cancer-causing type3.

When to Seek Care

Get a same-day appointment for heavy bleeding, soaking a pad or tampon every hour for more than 2 hours; call 911 if it comes with dizziness, fainting, chest pain or breathlessness26. During chemotherapy, a fever of 100.5ยฐF (38ยฐC) or higher needs urgent medical attention27. Contact your doctor urgently, or your local urgent-care line, if you have a stomachache and unusual bleeding or abnormal discharge from your vagina28. See your doctor for bleeding during or after sex, between periods or after menopause, or unusual discharge, and do not wait for your next screening29.

📬

Get new guides in your inbox. Once a month: new condition guides and research updates, including the trials that did not work. Free, no spam, and you can unsubscribe in one click.

Sign up

Next Steps

Screening and Your Oncology Team Come First

Stay current on screening, and keep it up after treatment, because vaccination does not replace it. If you are in treatment, nutrition supports your oncology team's plan by helping maintain weight and muscle. Clear every supplement with your oncology team first.

Explore Vaginal / Vulvar Cancer โ†’ Explore Uterine / Endometrial Cancer โ†’

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed October 20, 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.7 Nothing on this page treats cervical cancer, and it is worth being blunter than usual here, because cervical cancer is close to the most preventable cancer there is and the prevention is not dietary. Persistent infection with high-risk human papillomavirus causes virtually all of it. HPV vaccination prevents the infection, and screening with cervical cytology and HPV testing detects changes years before they become cancer, when treatment is simple and highly effective. Those two things are the whole game. Get vaccinated if you are eligible, and never skip a screening cycle, including after treatment. Nutrition supports you through treatment and general health; it does not clear HPV and it does not substitute for a Pap test. Diet and supplements are not an alternative to surgery, chemotherapy, radiation therapy or immunotherapy, and no dietary change should delay or replace treatment decided with your oncology team. Several supplements interact with cancer treatment, so tell your oncology team about every supplement you take.

  1. On cause: persistent infection with high-risk HPV types, particularly 16 and 18, is found in close to all cervical cancers. Most HPV infections clear spontaneously within one to two years; it is persistence that carries risk. Smoking, immunosuppression (including HIV) and long-term oral contraceptive use are cofactors. ↩
  2. On vaccination: HPV vaccination is highly effective at preventing infection with the covered types and the precancerous lesions they cause, with the greatest benefit before exposure. Population data from countries with high coverage show substantial falls in high-grade lesions and, increasingly, in invasive cervical cancer. US guidance recommends routine vaccination in adolescence with catch-up, and shared decision-making up to age 45. This is the single highest-leverage action available on this page. ↩
  3. On screening: cytology, HPV testing or co-testing at guideline intervals detects precancer reliably, and treating cervical intraepithelial neoplasia prevents progression. Screening continues after vaccination, because vaccines do not cover every oncogenic type. Most cervical cancers occur in people who were never screened or not screened on schedule. ↩
  4. On treatment: management depends on stage, and includes excisional procedures for precancer, surgery for early invasive disease, and chemoradiation for locally advanced disease, with immunotherapy added in advanced or recurrent settings. Fertility-sparing options exist for selected early cases and are worth asking about before treatment starts. ↩
  5. On nutrition during treatment: pelvic radiation therapy commonly causes diarrhea, and radiation enteritis or proctitis can persist. Maintaining protein and energy intake, managing symptoms, and correcting anemia support tolerance of treatment. This is where dietary attention genuinely helps. ↩
  6. On folate, antioxidants and HPV clearance: observational studies have associated better folate, vitamin C, carotenoid and vitamin D status with a higher likelihood of clearing HPV and lower risk of progression. These are associations in people whose diets and circumstances differ in many ways. No large randomized trial has shown that supplementation clears HPV, and no randomized trial has shown that it prevents cervical cancer. Eat well; do not treat it as an alternative to screening. ↩
  7. National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu/mic. ↩
  8. On HPV vaccination: in Scotland, women vaccinated at 12 to 13 had an 88% lower rate of CIN 2 or worse at their first screen at age 20, and effectiveness against CIN 3 or worse was 86% when vaccinated at 12 to 13 against 51% at 17, PubMed 30944092. ↩
  9. On green tea extract: in the largest randomized placebo-controlled trial, 98 women with persistent high-risk HPV and CIN 1 took 800 mg EGCG or placebo daily for 4 months, with no difference in HPV or CIN 1 clearance, PubMed 24388920. ↩
  10. On DIM: in a randomized placebo-controlled trial of oral DIM for 12 weeks in 64 women with CIN 2 or 3, there was no statistically significant difference in any outcome between DIM and placebo, PubMed 19939441. ↩
  11. On shiitake mycelium extract: in a randomized, placebo-controlled phase II trial of 50 women with persistent high-risk HPV, 14 of 22 on 3 g daily tested HPV negative after 6 months, and 2 of 19 on placebo at 12 months (the groups were reported at different time points), PubMed 35814366. ↩
  12. On bacterial vaginosis: a meta-analysis of 12 studies in 6,372 women found bacterial vaginosis associated with cervical HPV infection, odds ratio 1.43, PubMed 21223574. ↩
  13. On screening in the US: the US Preventive Services Task Force recommends a cervical cytology (Pap) test every 3 years from 21 to 29, and from 30 to 65 a choice of cytology every 3 years, high-risk HPV testing alone every 5 years or both together every 5 years; an update is in progress, USPSTF, cervical cancer screening. ↩
  14. On screening in the UK: the NHS invites everyone with a cervix for screening every 5 years from 25 to 64, does not screen under 25 partly because abnormal cell changes often go back to normal in younger women, lets anyone who missed a test book without waiting for an invitation, and advises not waiting for screening if you have symptoms such as bleeding between periods, during or after sex or after menopause, NHS, when you'll be invited for cervical screening. ↩
  15. On US statistics: SEER projects 13,490 new cases of cervical cancer and 4,200 deaths in the US in 2026. Five-year relative survival (2016 to 2022) was 91.8% when the cancer was confined to the cervix (41% of cases), 64.0% after spread to regional lymph nodes (37%) and 20.5% after spread to distant organs (16%), SEER, cervical cancer. ↩
  16. On what Group 1 means: the World Health Organization explains that IARC classifications describe the strength of the evidence that something causes cancer, not the level of risk, so processed meat sharing Group 1 with tobacco smoking does not make them equally dangerous; the link for processed meat is with colorectal cancer, WHO, red and processed meat. ↩
  17. On green tea extract: the NIH National Center for Complementary and Integrative Health notes that liver injury, though uncommon, has been reported mainly with green tea extract tablets or capsules, that green tea contains caffeine, and that anyone who is or might be pregnant should ask a health care provider about caffeine intake, NCCIH, green tea. ↩
  18. On supplements during pelvic radiation therapy: a 2021 meta-analysis of 23 randomized trials in 1,919 patients found that probiotics lowered the risk of diarrhea (relative risk 0.71), while glutamine had no effect on acute bowel symptoms (relative risk 1.05), PubMed 34027139. ↩
  19. On cervical cancer types: the American Cancer Society states that most cervical cancers, up to 9 out of 10, are squamous cell carcinomas, that most others are adenocarcinomas, that adenosquamous or mixed carcinomas are less common, and that almost all cervical cancers are one of these, with other types such as sarcoma rare, American Cancer Society, what is cervical cancer. ↩
  20. On cause and progression: the World Health Organization states that the immune system clears most HPV infections, that persistent infection with high-risk types can cause precancer, that it usually takes 15 to 20 years for abnormal cells to become cancer, or 5 to 10 years with a weakened immune system such as untreated HIV, that women living with HIV are 6 times more likely to develop cervical cancer and should be screened every 3 to 5 years from 25, that HPV types 16 and 18 cause around 76% of cervical cancers, and that other sexually transmitted infections, number of births, young age at first pregnancy, hormonal contraception and smoking raise the risk of progression, WHO, cervical cancer fact sheet. ↩
  21. On HPV in cervical cancer: a worldwide analysis of cervical cancer specimens published in 1999 found HPV in 99.7% of adequate samples, and the authors concluded that HPV is present in virtually all cervical cancers, PubMed 10451482. ↩
  22. On risk factors: NHS guidance states that nearly all cervical cancers are caused by high-risk HPV. Its listed risk factors are a weakened immune system such as HIV; having several children or a child before 17; smoking; and taking birth control pills for more than 5 years, which only slightly raises risk and for many people is outweighed by its benefits. It names screening and HPV vaccination as the best protection; condoms and stopping smoking are further ways to lower risk, NHS, causes of cervical cancer. ↩
  23. On HPV vaccination in the US: the National Cancer Institute reports that US guidance recommends HPV vaccination routinely at 11 or 12 (from as early as 9) and for everyone through age 26 who was not adequately vaccinated; from 27 to 45 it is not routine, but clinicians can discuss it with people not vaccinated earlier, NCI, HPV vaccines. ↩
  24. On HPV vaccination in the UK: the NHS offers the HPV vaccine to all children aged 12 to 13, free catch-up to girls and eligible boys until their 25th birthday, and vaccination to some people at higher risk, including people with HIV, NHS, HPV vaccine. ↩
  25. On exercise during treatment: an ASCO guideline based on 52 systematic reviews and 23 further randomized trials found that exercise during cancer treatment improved fitness, strength and fatigue, and recommends regular aerobic and resistance exercise during treatment given with curative intent; it found the evidence for other diet and weight-loss interventions during treatment very limited, PubMed 35576506. ↩
  26. On heavy bleeding: the American College of Obstetricians and Gynecologists lists bleeding after sex, bleeding between periods and bleeding that soaks through a pad or tampon every hour as abnormal, and advises emergency care right away for anyone changing pads or tampons every hour for more than 2 hours in a row who also has chest pain, shortness of breath, and lightheadedness or dizziness, ACOG, abnormal uterine bleeding. ↩
  27. On fever during treatment: the National Cancer Institute states that infections during cancer treatment can be life-threatening and need urgent medical attention, that treatments such as chemotherapy raise the risk, and lists a fever of 100.5ยฐF (38ยฐC) or higher among the signs, NCI, infection and neutropenia. ↩
  28. On belly pain with vaginal bleeding: NHS guidance advises asking for an urgent appointment with a doctor or getting help from NHS 111 for a stomachache together with unusual bleeding or abnormal discharge from the vagina, and calling emergency services for a stomachache that comes on very suddenly or is severe, NHS, stomach ache. ↩
  29. On symptoms: NHS guidance lists unusual vaginal bleeding (including during or after sex, between periods, after menopause or heavier periods than usual), changes to vaginal discharge, pain during sex and pain in the lower back, pelvis or lower belly; it advises seeing a doctor for any of them, NHS, symptoms of cervical cancer. ↩
  30. Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of long-term marine omega-⁠3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021;144(25):1981-⁠1990. PubMed 34612056. Seven trials with 81,210 people followed for about 5 years: omega-⁠3 supplements were linked to a higher risk of atrial fibrillation (hazard ratio 1.25), more so in trials of more than 1 g a day (1.49), and the risk rose with each additional gram. ↩